We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.49B
AUM Growth
+$329M
Cap. Flow
+$1.05B
Cap. Flow %
16.14%
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$112M
2
SWKS icon
Skyworks Solutions
SWKS
+$103M
3
STM icon
STMicroelectronics
STM
+$87.3M
4
ASML icon
ASML
ASML
+$71.6M
5
PANW icon
Palo Alto Networks
PANW
+$64.4M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$169M
2
COO icon
Cooper Companies
COO
+$103M
3
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$102M
4
LRCX icon
Lam Research
LRCX
+$78.9M
5
KLAC icon
KLA
KLAC
+$76.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.94%
2 Technology 31.31%
3 Financials 8.29%
4 Industrials 7.52%
5 Communication Services 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKE icon
201
Nike
NKE
$61.9B
$7.93M 0.12%
+77,645
New +$9.18M
LCAA
202
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$7.84M 0.12%
800,000
+750,000
+1,500% +$7.35M
OKLO
203
Oklo
OKLO
$6.76B
$7.72M 0.12%
800,000
– –
FTVI
204
DELISTED
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
$7.64M 0.12%
+776,019
New +$7.63M
BIIB icon
205
Biogen
BIIB
$30B
$7.63M 0.12%
37,412
-16,655
-31% -$3.4M
EL icon
206
Estee Lauder
EL
$30.4B
$7.58M 0.12%
29,781
-10,162
-25% -$2.58M
AMLX icon
207
Amylyx Pharmaceuticals
AMLX
$2.26B
$7.52M 0.12%
390,229
– –
DGX icon
208
Quest Diagnostics
DGX
$25.7B
$7.42M 0.11%
+55,833
New +$7.61M
ALTI icon
209
AlTi Global
ALTI
$399M
$7.37M 0.11%
749,999
– –
PDCO
210
DELISTED
Patterson Companies, Inc.
PDCO
$7.36M 0.11%
+243,050
New +$7.61M
RACB
211
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$7.33M 0.11%
750,000
– –
AUS
212
DELISTED
Austerlitz Acquisition Corporation I
AUS
$7.31M 0.11%
750,000
– –
ITCI
213
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.27M 0.11%
+127,342
New +$7.22M
DISH
214
DELISTED
DISH Network Corp.
DISH
$7.11M 0.11%
396,421
+248,609
+168% +$6.03M
KDNY
215
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$7.01M 0.11%
+401,023
New +$6.29M
XENE icon
216
Xenon Pharmaceuticals
XENE
$6.06B
$6.96M 0.11%
+228,928
New +$6.92M
AFMD
217
DELISTED
Affimed
AFMD
$6.95M 0.11%
+251,008
New +$8.59M
CERE
218
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$6.76M 0.1%
255,533
-106,220
-29% -$3.02M
PMVP icon
219
PMV Pharmaceuticals
PMVP
$59.2M
$6.7M 0.1%
469,883
-248,210
-35% -$3.61M
SNX icon
220
TD Synnex
SNX
$20.4B
$6.69M 0.1%
+73,401
New +$7.29M
DDOG icon
221
Datadog
DDOG
$95.4B
$6.54M 0.1%
+68,689
New +$7.55M
ALT icon
222
Altimmune
ALT
$552M
$6.44M 0.1%
550,685
-295,933
-35% -$1.82M
CNTA
223
DELISTED
Centessa Pharmaceuticals
CNTA
$6.4M 0.1%
1,314,652
+432,019
+49% +$2.76M
XRAY icon
224
Dentsply Sirona
XRAY
$2.68B
$6.4M 0.1%
+179,001
New +$7.24M
VRDN icon
225
Viridian Therapeutics
VRDN
$2.09B
$6.39M 0.1%
552,371
+331,114
+150% +$4.45M
7 8
9
10 11

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

Woodline Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.

  • Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
  • Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
  • Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
  • Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
  • Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
  • Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.